| Sulindac studied in …STUDIED_INderived22 of 22show fewer |
|---|
| → studied in | NCT04207944Phase 2 · active not recruiting The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial) · 22 trials list this drug (1 active) | — | — | Pancreatic Intraductal Papillary Mucinous Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01761877Phase 2 · completed NSAID Effects on Clinical and Imaging Breast Biomarkers · 22 trials list this drug (1 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01483144Phase 3 · completed Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00299195NA · completed A Randomized Study of Sulindac in Oral Premalignant Lesions · 22 trials list this drug (1 active) | — | — | Benign Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068419Phase 2 · completed Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor · 22 trials list this drug (1 active) | — | — | Desmoid Fibromatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00841204Phase 2 · completed Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392665Phase 2 · terminated Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck · 22 trials list this drug (1 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01843179Phase 2 · withdrawn Sulindac for Patients With AML · 22 trials list this drug (1 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335504Phase 2 · completed Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia · 22 trials list this drug (1 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01187901Phase 2 · completed A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01856322Phase 2 · terminated Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer · 22 trials list this drug (1 active) | — | — | Colorectal Neoplasm,Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00343629NA · completed Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers · 22 trials list this drug (1 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118365Phase 3 · completed Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00755976Phase 2 · completed Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma · 22 trials list this drug (1 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01636128Phase 2 · withdrawn Urinary Biomarker Study With Sulindac and Difluoromethylornithine · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368927Phase 2 · completed Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia · 22 trials list this drug (1 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00039520Phase 2 · completed Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer · 22 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00245024Phase 1 · completed Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer · 22 trials list this drug (1 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00062023Phase 2 · terminated Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer · 22 trials list this drug (1 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003365NA · terminated Sulindac and Plant Compounds in Preventing Colon Cancer · 22 trials list this drug (1 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00176618NA · terminated The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00319007Phase 2 · unknown Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis · 22 trials list this drug (1 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |